Location History:
- Montreal, CA (2020)
- Cantley, CA (2020 - 2023)
Company Filing History:
5 out of 5 
1 out of 1 
1 out of 1 Years Active: 2020-2025
Title: Celebrating the Innovations of Inventor Nancy Tawil
Introduction
Nancy Tawil, a pioneering inventor based in Cantley, CA, has made significant strides in the field of microbiology and biomedical engineering. With a remarkable portfolio of six patents to her name, Tawil is dedicated to enhancing the safety and efficacy of bacteriophage products while promoting innovative solutions for bacterial infections.
Latest Patents
One of her latest patents revolves around the "Disinfection of Bacteriophages Products Using Supercritical Carbon Dioxide." This innovative method offers a sterilization process that retains the activity and infectivity of bacteriophages while causing minimal damage to their structural integrity. Additionally, Tawil has developed a composition comprising amino acid polymers and a bioactive agent for the treatment, reduction, or prevention of bacterial infections in wounds. This method includes applying a film on the wound, made from a biodegradable polymer with bacteriophages dispersed throughout, specifically using poly(ester amide urea).
Career Highlights
Throughout her career, Nancy Tawil has contributed her expertise to companies such as Phagelux Canada Inc. and Precision Biotix Technologies Inc. Her work has not only fostered advancements in microbiological applications but has also opened new avenues for research in sustainable and effective medical treatments.
Collaborations
Tawil has collaborated with notable professionals in her field, including Ramaz Katsarava and David Tugushi. Together, these innovative minds work towards revolutionizing the approach to battling bacterial infections and improving the products that harness bacteriophages.
Conclusion
Nancy Tawil's contributions to the realm of bacteriophages and her commitment to innovation illustrate her as a leading inventor paving the way for future advancements in medical treatments. Her patents reflect a promising future for combating bacterial infections, emphasizing the importance of continued research and development in this critical area.